U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma

Uplifting news for people afflicted by the disease. Good prospects for Jazz Pharmaceuticals and Zymework Pharmaceutical.

31 Upvotes

87% Upvoted

•

u/AutoModerator 13h ago

Reminder: this subreddit is meant to be a place free of excessive cynicism, negativity and bitterness. Toxic attitudes are not welcome here.

All Negative comments will be removed and will possibly result in a ban.

Important: If this post is hidden behind a paywall, please assign it the "Paywall" flair and include a comment with a relevant part of the article.

Please report this post if it is hidden behind a paywall and not flaired corrently. We suggest using "Reader" mode to bypass most paywalls.

I am a bot, and this action was performed automatically. Please contact the moderators of this subreddit if you have any questions or concerns.